Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

PHASE4CompletedINTERVENTIONAL
Enrollment

888

Participants

Timeline

Start Date

October 7, 2014

Primary Completion Date

November 29, 2017

Study Completion Date

January 2, 2018

Conditions
Overactive Bladder (OAB)
Interventions
DRUG

Mirabegron

oral tablet

DRUG

Placebo

oral tablet

Trial Locations (120)

11215

Site US00016, Brooklyn

14221

Site US00043, Williamsville

15236

Site US00180, Pittsburgh

20010

Site US00090, Washington D.C.

21401

Site US00025, Annapolis

23502

Site US00086, Norfolk

23606

Site US00170, Newport News

27103

Site US00166, Winston-Salem

27403

Site US00122, Greensboro

27609

Site US00161, Raleigh

28025

Site US00132, Concord

28209

Site US00153, Charlotte

28401

Site US00165, Wilmington

29461

Site US00082, Moncks Corner

29464

Site US00162, Mt. Pleasant

31406

Site US00005, Savannah

32003

Site US00027, Fleming Island

32129

Site US00035, Port Orange

32132

Site US00018, Edgewater

32713

Site US00002, DeBary

32720

Site US00001, DeLand

Site US00017, DeLand

33016

Site US00151, Hialeah

33060

Site US00021, Pompano Beach

33134

Site US00080, Coral Gables

33135

Site US00037, Miami

33144

Site US00029, Miami

33161

Site US00007, North Miami

33173

Site US00042, Miami

33458

Site US00179, Jupiter

33606

Site US00099, Tampa

33709

Site US00075, St. Petersburg

33805

Site US00076, Lakeland

34601

Site US00064, Brooksville

34744

Site US00057, Kissimmee

35801

Site US00066, Huntsville

36608

Site US00148, Mobile

37064

Site US00053, Franklin

37211

Site US00052, Nashville

37421

Site US00154, Chattanooga

37620

Site US00032, Bristol

44094

Site US00084, Mentor

44109

Site US00095, Cleveland

44130

Site US00015, Middleburg Heights

44313

Site US00067, Akron

45249

Site US00050, Cincinnati

46143

Site US00060, Greenwood

47130

Site US00046, Jeffersonville

48604

Site US00093, Saginaw

49009

Site US00003, Kalamazoo

49503

Site US00056, Grand Rapids

50266

Site US00134, West Des Moines

53715

Site US00062, Madison

55435

Site US00024, Edina

56377

Site US00137, Sartell

58103

Site US00085, Fargo

59102

Site US00159, Billings

66202

Site US00045, Overland Park

67010

Site US00104, Augusta

67114

Site US00105, Newton

68701

Site US00070, Norfolk

70601

Site US00172, Lake Charles

72120

Site US00063, Little Rock

72205

Site US00081, Little Rock

73069

Site US00102, Norman

76054

Site US00174, Hurst

77030

Site US00131, Houston

78209

Site US00068, San Antonio

78229

Site US00071, San Antonio

Site US00100, San Antonio

78705

Site US00175, Austin

80220

Site US00039, Denver

80239

Site US00004, Denver

80907

Site US00026, Colorado Springs

83642

Site US00041, Boise

84088

Site US00023, West Jordan

84107

Site US00044, Salt Lake City

84124

Site US00036, Salt Lake City

85715

Site US00020, Tucson

85745

Site US00019, Tucson

87102

Site US00140, Albuquerque

89148

Site US00014, Las Vegas

90017

Site US00112, Los Angeles

90027

Site US00034, Los Angeles

90211

Site US00048, Beverly Hills

90212

Site US00142, Beverly Hills

90716

Site US00150, Hawaiian Gardens

92117

Site US00135, San Diego

92120

Site US00139, San Diego

92562

Site US00010, Murrieta

92801

Site US00176, Anaheim

93454

Site US00144, Santa Maria

94305

Site US00083, Stanford

97239

Site US00103, Portland

98150

Site US00167, Seattle

98405

Site US00098, Tacoma

99503

Site US00009, Anchorage

06320

Site US00040, New London

02301

Site US00091, Brockton

02740

Site US00006, New Bedford

02472

Site US00145, Watertown

08816

Site US00113, East Brunswick

08901

Site US00111, New Brunswick

T5G 0B7

Site CA00130, Edmonton

V6J1S3

Site CA00074, Vancouver

L6T 4S5

Site CA00155, Brampton

N0N1G0

Site CA00123, Corunna

P3E 3Z9

Site CA00169, Greater Sudbury

L8N 4A6

Site CA00126, Hamilton

N6A 4V2

Site CA00118, London

N7T4X3

Site CA00116, Sarnia

M4S 1Y2

Site CA00168, Toronto

G6W 0M6

Site CA00164, Lévis

H2Y 1S1

Site CA00158, Montreal

H9R4S3

Site CA00073, Point Claire

Site CA00106, Point Claire

J1H 1Z1

Site CA00156, Sherbrooke

J1H5N2

Site CA00061, Sherbrooke

G1S2L6

Site CA00129, Québec

G1X 0B6

Site CA00160, Québec

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT02216214 - Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB) | Biotech Hunter | Biotech Hunter